Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Cancer Treatment Reports|February 1, 1982
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancerD S Ettinger, S E Order, M D Wharam, et al.
The New England Journal of Medicine|August 25, 1983
Immune thrombocytopenic purpura. Use of a 125I-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgGA F LoBuglio, W S Court, L Vinocur, et al.
American Journal of Clinical Oncology|February 20, 1999
Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural historyB E Epstein, T F Pajak, T L Haulk, et al.
Cancer Drug Delivery|January 1, 1984
Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancersP K Leichner, J L Klein, E K Fishman, et al.
American Journal of Clinical Oncology|October 1, 1985
Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapyD S Ettinger, P K Leichner, S S Siegelman, et al.
Cancer Treatment Reports|July 1, 1981
Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lungM D Abeloff, D S Ettinger, S E Order, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|July 22, 1998
Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathyJ J Feldmeier, D A Davolt, W S Court, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1982
Risk factors in interstitial pneumonitis following allogenic bone marrow transplantationJ L Pino y Torres, D S Bross, W C Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1991
Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01G B Stillwagon, S E Order, C Guse, et al.
Pageof 10